<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="805">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 27, 2015</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02464865</url>
  </required_header>
  <id_info>
    <org_study_id>Si656/2014</org_study_id>
    <nct_id>NCT02464865</nct_id>
  </id_info>
  <brief_title>Thiamin Deficiency in Obese Thai Children</brief_title>
  <official_title>Thiamin Deficiency in Obese Thai Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <authority>Thailand: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is aimed to assess the prevalence of thiamin deficiency in obese Thai children.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a cross-sectional study. The objectives of the study are to determine the
      prevalence of thiamin deficiency in obese Thai children and to assess the associations of
      dietary factors and thiamin deficiency.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening</study_design>
  <primary_outcome>
    <measure>abnormal thiamin pyrophosphate effect</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Thiamin pyrophosphate effect will be measured by a blood test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>consumption of thiaminase-containing foods and thiamin antagonist-containing foods</measure>
    <time_frame>7 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Food diary and food frequency questionaire will be required to evaluate food consumption</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Obesity</condition>
  <condition>Child</condition>
  <condition>Thiamine Deficiency</condition>
  <arm_group>
    <arm_group_label>Thiamine 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>presence of severe symptoms and signs of thiamine deficiency: heart failure, convulsion, coma, loss of ankle and knee jerks with muscular wasting and paralysis (typically symmetrical foot- and wrist-drop)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-thiamine</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>no symptoms and signs of thiamine deficiency</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Thiamine 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>presence of mild symptoms and signs of thiamine deficiency; peripheral neuropathy alone (paraesthesia of hands and feet)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiamine 1</intervention_name>
    <description>If severe symptoms and signs of thiamine deficiency are present, thiamine is prescribed.
Intervention 1 : severe symptom (heart failure, convulsion, or coma) : 50 mg thiamin administered very slowly intravenously, followed by a daily intramuscular dose of 10 mg for a week, and finally followed by 3-5 mg of thiamine per day orally for at least 6 weeks</description>
    <arm_group_label>Thiamine 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>no symptoms and signs of thiamine deficiency</description>
    <arm_group_label>Non-thiamine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Thiamine 2</intervention_name>
    <description>If symptoms and signs of thiamine deficiency are present, thiamine is prescribed.
If mild symptom : a daily oral dose of 10 mg thiamin during the first week, followed by 3-5 mg of thiamin per day orally for at least 6 weeks</description>
    <arm_group_label>Thiamine 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  obese : weight for height &gt; median + 3 standard deviations

          -  simple obesity

        Exclusion Criteria:

          -  pathological obesity

          -  chronic diseases e.g. cerebral palsy, metabolic disease, etc.

          -  diseases of red blood cells

          -  on medication e.g. steroid, multivitamins, thiamine-containg vitamins, diuretic drugs

          -  hemodialysis or peritoneal dialysis

          -  bariatric surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>7 Years</minimum_age>
    <maximum_age>15 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Densupsoontorn N, Jirapinyo P, Kangwanpornsiri C. Micronutrient deficiencies in obese Thai children. Asia Pac J Clin Nutr. 2013;22(3):497-503. doi: 10.6133/apjcn.2013.22.3.06.</citation>
    <PMID>23945419</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <lastchanged_date>June 3, 2015</lastchanged_date>
  <firstreceived_date>May 18, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>thiamine deficiency</keyword>
  <keyword>obese children</keyword>
  <keyword>Thai</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Beriberi</mesh_term>
    <mesh_term>Thiamine Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thiamine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
